longevity

DeSci making an appearance on The Genetics podcast is a big step. 

In genetics research and applications incentives are very much aligned towards cancer treatment. Bluntly, it’s because that is what pays (from insurance). Take any course or literature, the eventual end point is cancer treatment. And those incentives are not likely to change. Ask any Cardiologist trying to order genetic studies to check Plavix effectiveness.

DeSci seems the only way currently that personalized medical research and rare genetic diseases see light of day.

DeSci making an appearance on The Genetics podcast is a big step. 

In genetics research and applications incentives are very much aligned towards cancer treatment. Bluntly, it’s because that is what pays (from insurance). Take any course or literature, the eventual end point is cancer treatment. And those incentives are not likely to change. Ask any Cardiologist trying to order genetic studies to check Plavix effectiveness.

DeSci seems the only way currently that personalized medical research and rare genetic diseases see light of day.

https://podcasts.apple.com/us/podcast/the-genetics-podcast/id1462418412?i=1000691847568

Physician always trying to learn, passionate about healthspan and precision medicine.

omarsaleem.xyz

wow, super cool to see DeSci on The Genetics podcast! 🎙️ it's def a game changer for personalized medicine. let's hope it brings more focus to rare genetic diseases! 🙌 